Unión Europea - español - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - fibrosis quística - otros productos del sistema respiratorio - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Unión Europea - español - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agentes antineoplásicos - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Unión Europea - español - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agentes antineoplásicos - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

pharmacia grupo pfizer, s.l. - ropinirol hidrocloruro - excipientes: lactosa monohidrato,croscarmelosa sodica,croscarmelosa sodica - agentes dopaminÉrgicos - agonistas dopaminérgicos - ropinirol

Unión Europea - español - EMA (European Medicines Agency)

norgine b.v. - maltol férrico - anemia, deficiencia de hierro - preparaciones antianémicas - feraccru está indicado en adultos para el tratamiento de la deficiencia de hierro.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

swan pond investments limited - acido zoledronico monohidrato - excipientes: manitol (e-421),citrato sodico tribasico dihidratado - agentes que afectan la estructura Ósea y la mineralizaciÓn - bifosfonatos - Ácido zoledrónico

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

swan pond investments limited - acido zoledronico monohidrato - excipientes: manitol (e-421),citrato sodico tribasico dihidratado - agentes que afectan la estructura Ósea y la mineralizaciÓn - bifosfonatos - Ácido zoledrónico

Unión Europea - español - EMA (European Medicines Agency)

ultragenyx germany gmbh - evinacumab - hipercolesterolemia - agentes modificadores de lípidos - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

exeltis healthcare s.l. - dienogest; etinilestradiol - comprimido recubierto con pelÍcula - 2 mg/0,03 mg - dienogest 2 mg; etinilestradiol 0,03 mg - dienogest y etinilestradiol

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios cinfa s.a. - dienogest; etinilestradiol - comprimido recubierto con pelÍcula - 2 mg/0,03 mg - dienogest 2 mg; etinilestradiol 0,03 mg - dienogest y etinilestradiol